Rchr
J-GLOBAL ID:202001017716669579   Update date: Oct. 30, 2024

Maeda Hideki

マエダ ヒデキ | Maeda Hideki
Affiliation and department:
Job title: Professor
Homepage URL  (2): https://www.my-pharm.ac.jp/education/kdb/kyoin/kyoin_159.htmlhttps://www.my-pharm.ac.jp/en/research/laboratories/post.html
Research theme for competitive and other funds  (4):
  • 2023 - 2026 Study on surrogate end points of clinical trials for supporting drug approvals.
  • 2022 - 2025 Research on product recalls of pharmaceuticals and medical devices in Japan.
  • 2021 - 2024 Research on the reconstruction of post-marketing safety measures for pharmaceutical products in view of the next system revision
  • 2020 - 2023 Consideration on drug lag, start timing of clinical development and review timefor oncology drug in Japan.
Papers (40):
  • Natsuko Kameyama, Aoi Hosaka, Hideki Maeda. Has risk management plan system influenced the speed of package insert revisions in Japan?. Frontiers in Medicine. 2024
  • Edo K, 真秀 川野, Hideki Maeda. Comparison of regulatory approval system for medicines in emergency among Japan, the United States, the United Kingdom, Europe, and China. PloS one. 2024
  • Makiko Mochizuki, Hideki Maeda. Trends in the market for drug delivery devices categorized as combination drugs and medical devices and regulatory challenges for autoinjectors in Japan. Frontiers in Medical Technology. 2024. 6
  • Haruto Hayashi, Takehide Nogita, Hideki Maeda. A Qualitative Interview Study on Expanded Access Clinical Trials for Compassionate Use in Japan. Patient Preference and Adherence. 2024
  • Natsuko Kameyama, Aoi Hosaka, Hideki Maeda. Current situation and issues regarding termination of risk management plans in Japan. Frontiers in Medicine. 2024
more...
MISC (39):
  • 前田 英紀. タイの医療保障制度について-Health Security Systems in Thailand. Monthly IHEP. 2024. 337. 31-36
  • 前田英紀. Surrogate end points of confirmatory studies for approval of anticancer drug. 月刊Precision Medicine. 2024. 7. 2. 156-160
  • AKAISHI Koko, SATOMI Tomomi, MAEDA Hideki. International Comparison of Reporting Systems for Medical Device Malfunctions. Regulatory Science of Medical Products. 2024. 14. 3. 293-306
  • 川野真秀, 前田英紀. 安定確保医薬品に関する日本と諸外国との比較検討. ジェネリック研究(CD-ROM). 2024. 18
  • SOH Hyunseo, 大野絵里, 三角俊裕, 前田英紀. Cross-sectional Study on Gender Disparities in Professors of Pharmacy Departments of Japanese and Korean University. 日本薬学会年会要旨集(Web). 2024. 144th
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page